Imagion Biosystems is pleased to present the Company’s annual report for the year ending 31 December 2017.
Read the 2017 Annual Report to Shareholders.
Imagion Initiates Collaboration with Wayne State University to Develop Advanced Molecular Imaging Capabilities to Enable AI Cancer Diagnostics
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging